Pfizer Inc. announced an additional agreement with the United Kingdom (UK) government to supply an additional 2.5 million treatment courses of its investigational candidate...
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™...
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United Kingdom Government will purchase an additional...
TandemAI announced it has raised $25 million in Seed and pre-Series A financing to advance its proprietary computational platform and expansion of its wet...
K2bio has announced Ansun BioPharma, a clinical-stage biopharmaceutical company, together with its wholly-owned subsidiary, Anovac, as an addition to the K2bio community. Ansun's mission...
